{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-001717","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.244538+00:00","generated_at":"2026-06-20T17:44:23.053385+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Preliminary FY2022 revenue exceeds $44M (60% growth); profitable Q4 and FY; COO appointed","bullets":["Preliminary Q4 2022 revenues expected to exceed $13M; full-year 2022 revenues exceed $44M (60% growth over 2021).","Sensus expects both Q4 and full-year 2022 to be profitable; Q4 aesthetics revenue over $500K.","Magdalena Martinez named COO, replacing Nicolas Soro, effective January 3, 2023. She previously served as VP of Operations.","Company plans to expand sales force, increase trade show presence, and submit new technologies to FDA in H2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-001717","json":"https://secwatch.observer/filing/0001213900-23-001717.json","markdown":"https://secwatch.observer/filing/0001213900-23-001717.md","text":"https://secwatch.observer/filing/0001213900-23-001717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/ea171415-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:44:23.053385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38f769946bbfb34290754b7a12f3f38c65a852ed","claim":"Sensus Healthcare, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue exceed $13 million.","evidence_excerpt":"PRESS RELEASE, DATED JANUARY 5, 2023. Exhibit 99.1 Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60% BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2022"},{"label":"Revenue","value":"exceed $13 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"c68ec71f71","claim":"Nicolas Soro departed as Chief Operating Officer at Sensus Healthcare, Inc..","evidence_excerpt":"On January 3, 2023, Magdalena Martinez was elected Chief Operating Officer of Sensus, replacing Nicolas Soro.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"e2c08896c5","claim":"Magdalena Martinez was elected as Chief Operating Officer at Sensus Healthcare, Inc..","evidence_excerpt":"On January 3, 2023, Magdalena Martinez was elected Chief Operating Officer of Sensus, replacing Nicolas Soro.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}